Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) ...

WinTrust Pharmaceuticals Ltd. Top Ayurvedic Medicine Manufacturer in India has earned its reputation as a trusted name in the ...

India's pharmaceutical sector is targeting $130 billion by 2030 and biotechnology is aiming for $300 billion by the same year ...

The Nippon India Pharma Fund - Growth has an AUM of 8638.23 crores & has delivered CAGR of 27.97% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.81%. The minimum ...

* India has emrged as the medial tourism hub of the world providing cost-effective treatments with the latest technology enabled by several pathbreaking reforms and provisions. * Access to affordable ...

Indian pharmaceutical companies have made major ... robust Standard Operating Procedures (SOPs), and ongoing employee training, Jain said. According to Jain, the senior leadership has prioritised ...

New Delhi, Dec 26 (PTI) As technological advancements like AI, machine learning and precision medicine revolutionise drug discovery, manufacturing and patient care, Indian pharmaceutical industry ...

As every pharma company invests in digital technology ... we are overlooking the potential of such techniques for internal training. The way in which we communicate has changed radically over ...

A few Indian pharma companies have established dedicated research companies in major markets like the US and Europe. (Image Credits: Pixabay) Indian pharma players have increased their focus on ...

With high connectivity and spillover, the pharmaceutical industry can contribute to Vietnam’s becoming a high-income country ...

In a significant step toward ensuring global quality standards, Indian pharmaceutical, nutraceutical, and medical device ...

India's healthcare sector is set to reach $320 billion by 2028, fueled by advancements in pharmaceuticals, biotechnology, and ...